Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azasetron for prevention of chronic pain after thoracic surgery
ChiCTR2200060139Phase 4Recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azasetron in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoint: visual analogue scale of pain. Started Jul 2022; status: recruiting.
02
Drugs
azasetron
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2200060139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060139.